might have a positive effect on cell-based therapeutic angiogenesis induced by the implantation of BMCs. Conversely, it is also possible that IL-1 may be unfavorable for the survival of implanted cells because of its potent role as an inflammation mediator. Therefore, it is necessary to investigate how the increased expression of IL-1 in the acute stage of ischemia tissue effects BMC on the induction of angiogenesis.
Methods

Separation and Culture of BMCs
BMCs were harvested from the femur and tibia of 16-20-week-old male Zucker obese rats, 1 chosen for this study because diabetes mellitus is associated with high risk for coronary ischemic events and patients with diabetes show an increased level of IL-1 .
11,12
The collected cells were suspended in heparinized phosphate-buffered saline (PBS) and density gradient centrifugation was carried out to remove erythrocytes. Cells were suspended at a density of 3×10 6 cells/ml in RPMI 1640 medium containing 15% fetal bovine serum (Gibco) and 1% penicillin -streptomycin (Gibco). In a preliminary experiment, we performed a dose -response study to investigate the effect of various concentrations of IL-1 (0, 1, 5, 25 ng/ml) on survival of cultured BMCs and we found the survival rate increased dose-dependently with 5 ng/ml IL-1 or less. However, the survival rate of BMCs cultured with 25 ng/ml IL-1 did not differ significantly from that of cells cultured with 5 ng/ml IL-1 (data not shown). Therefore, we cultured BMCs with 5 ng/ml IL-1 (IL-1 group) or without IL-1 (control group) for the subsequent experiments.
In Vitro Assessment of the Effect of Interleukin-1 on Angiogenic Potential of Bone Marrow Cells
Shu-Lan Qin, MD; Tao-Sheng Li, MD; Masaya Takahashi, MD; Kimikazu Hamano, MD Background Therapeutic angiogenesis for ischemic diseases has been successfully induced by the implantation of autologous bone marrow cells (BMCs). It is understood that interleukin (IL)-1 increases remarkably in ischemic tissue and has particular effects on angiogenesis. Thus, it is important to clarify how IL-1 would effect BMCs survival and angiogenic potential.
Methods and Results
The effect of IL-1 on BMCs survival, adhesion, and endothelial differentiation, as well as the production of angiogenic growth factors, was investigated using an in vitro assessment approach. BMCs were harvested from Zucker obese rats and cultured at a density of 3×10 6 cells/ml with 5 ng/ml IL-1 (IL-1 group) or without IL-1 (control group). Survival and adhesion of BMCs were significantly increased in the IL-1 group than in the control group after 1, 3, and 7 days of culture (p<0.01). Survival Analysis BMCs were cultured on 24-well plates with or without 5 ng/ml IL-1 and were harvested after 1, 3, and 7 days of culture. The total number of surviving cells was counted after staining with 0.4% trypan blue solution (Sigma). The cell survival rate was calculated as the number of surviving cells relative to the total number of seeded cells on day 0.
Adhesion Analysis
BMCs were cultured with or without 5 ng/ml IL-1 in 4-well Lab-Tek II chamber slides (Nalge Nunc) coated with 50 g/ml fibronectin. After 1, 3, and 7 days of culture, the supernatant was aspirated, and non-adherent cells were removed by 3 washes with 1 ml PBS. After fixation with 4% formaldehyde for 20 min and staining of nuclei with 4',6-dismino-2-phenylindole (DAPI) (Molecular Probes), adherent cells were counted in 10 random fields under a microscope at ×200 magnification. The mean number of adherent cells in each experiment was used for statistical analysis.
ELISA Assay
The concentration of VEGF in the supernatant was measured with an ELISA kit, according to the manufacturer's instructions (R&D Systems). After 1, 3, and 7 days of culture on 24-well plates with or without 5 ng/ml IL-1 , as described above, the supernatant of the culture medium was collected and added onto each well of the microtiter plate, which was pre-coated with anti-VEGF ployclonal antibody, and incubated for 2 h. Each well was washed with wash buffer and incubated with 100 l of enzyme-linked polyclonal antibody specific for VEGF for 2 h. Following washes, substrate solution was added to each well. After incubation for 30 min at room temperature, the enzyme reaction was stopped, and the intensity of each well was measured at 450 nm. The mean value of 2 assays was used for statistical analysis.
Immunocytochemistry
To examine endothelial differentiation, immunocytochemistry was performed as described previously but with a minor modification. 13 In brief, BMCs were cultured with or without 5 ng/ml IL-1 in 4-well Lab-Tek II chamber slides (Nalge Nunc) coated with 50 g/ml fibronectin. After 7 days of culture, non-attached cells were gently removed with PBS. Attached cells were fixed in 4% paraformaldehyde, then incubated with mouse monoclonal antibody against rat CD34 or rabbit polyclonal antibody against rat Flk-1 (Sigma) for 60 min. After a thorough washing, positive staining was detected by (phycoerythrin) PE-conjugated secondary antibodies. Nuclei were stained with DAPI (Molecular Probes). The positively stained cells were counted in 10 random fields under a microscope at ×200 magnification. The percentage of positive cells for CD34 or Flk-1 was calculated as the number of positively stained cells compared to the total number of attached cells.
Statistical Analysis
All results are expressed as mean ± SD. Statistical significance was evaluated using the unpaired t-test for comparisons between 2 means. Probability value of p<0.05 denoted statistical significance.
Results
Survival of BMCs
As shown in Fig 1, the survival rate of BMCs decreased gradually over time after culture with and without IL-1 . However, survival rates were significantly higher for cells cultured with IL-1 than for those cultured without IL-1 after 1, 3, and 7 days of culture. 
Adhesion of BMCs
The adhesion of BMCs increased over time both with and without the supplement of IL-1 . However, the mean number of adherent cells was significantly higher among cells cultured with IL-1 than among those cultured without IL-1 after 1, 3, and 7 days of culture. Quantitative analysis showed that the number of adherent cells in the IL-1 group was approximately 2-fold higher than in the control group after 7 days of cultivation (Fig 2) .
VEGF Production
The VEGF concentration in the medium increased with culture time of cells both with and without the supplement of IL-1 . Although there was no significant difference between the 2 groups at 1 day of culture, the concentration of VEGF in the IL-1 group was significantly higher than that in the control group after 3 and 7 days of culture (130.7± 2.9 pg/ml in IL-1 group vs 108.1±4.7 pg/ml in control group, and 258.9±16.6 0pg/ml in IL-1 group vs 164.7± 10.7 pg/ml in control group; p<0.01 for both comparisons, Fig 3) .
Endothelial Differentiation
The endothelial differentiation of BMCs was examined by direct observation of PE-labeled cells under fluorescent microscopy. We found that the number of cells expressing CD34 or Flk-1 in the control group was less than in the IL-1 group (Fig 4A) . Quantitative analysis also showed that the total number of cells expressing CD34 or Flk-1 in the A IL-1 group was significantly higher than in the control group (p<0.01, Fig 4B) . However, the percentage of cells positive for CD34 or Flk-1 did not differ significantly between the 2 groups (Fig 4C) .
Discussion
Although the mechanisms underlying angiogenesis induced clinically by the implantation of BMCs remain unclear, angiogenic potency is reported to agree with survival, adhesion, and endothelial differentiation of the implanted cells. 1, 3, 6 Several investigations have shown that the micro-environment is a unique way of regulating the homing, survival, and differentiation of implanted cells. 14, 15 With respect to acute ischemia, the important change in the micro-environment is the robust upregulation of inflammatory cytokines, such as IL-1 , 8 which is the inflammatory cytokine that possesses various biologic activities related to cell surface receptors. It is reported that IL-1 could effect BMCs through activation of IL-1 receptors that are consistent with the G-protein coupling and activation of a phospholipase. 10, 16 Therefore, we considered that IL-1 could be a very important local environment factor influencing the survival, adhesion, and differentiation of implanted BMCs.
In the present study, we found that IL-1 increased the survival of cultured BMCs, a finding that is supported by previous results showing that IL-1 synergized with colony-stimulating factors and other cytokines to promote the growth of BMCs. 17 Although we did not investigate which population of BMCs survived the best with the culture of IL-1 , previous studies show that IL-1 increases the in vitro survival of progenitor cells, such as hematopoietic stem cells. 16, 18 In addition, we also investigated the effect of IL-1 on adhesion of BMCs, because cell adhesion to the extracellular matrix is an important process that controls cell migration, survival, and differentiation. 19 Our data showed that adhesion of BMCs was significantly increased in the IL-1 group. As the expression of adhesion molecules was not measured, we do not know the precise mechanism for the regulation of adhesion of BMCs by IL-1 . However, it was reported previously that IL-1 can increase the expression of adhesion molecules, such as E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1, in cultured cells. 16, 20 It is also possible that the increased adhesion of BMCs associated with IL-1 might just be related to the positive effect of IL-1 on BMCs survival.
Previous investigations have demonstrated that therapeutic angiogenesis induced by implantation of BMCs is related to production of angiogenic cytokines, and to endothelial differentiation of BMCs. 1, 21, 22 It is important to clarify the effect of IL-1 on both these processes. Our results show that the concentration of VEGF in the supernatant was significantly higher after 3 and 7 days of culture with IL-1 and similarly, the total number of BMCs expressing CD34 or Flk-1 was significantly increased after 7 days of culture with IL-1 . However, there was no significant difference between the 2 culture conditions in the percentage of positively stained cells. Therefore, it is possible that the increased number of CD34 + or Flk-1 + cells among the BMCs cultured with IL-1 resulted just from the positive effect of IL-1 on the survival and adhesion of BMCs.
In summary, our in vitro investigations show that IL-1 significantly increases the adhesion and survival of BMCs. Furthermore, IL-1 also upregulates the release of VEGF and increases the total number of BMCs expressing CD34 or Flk-1. Although further in vivo studies are needed, our results suggest that IL-1 has a positive effect on the angiogenic potential of BMCs in vitro. Our results also support the choice of the acute phase of ischemia as the optimum stage for cell-based therapeutic angiogenesis because of the robust upregulation of IL-1 expression during this period.
